Would You Let Elon Musk Do THIS To You?

Elon Musk

(ReclaimingAmerica.net) – Would you volunteer to allow Elon Musk’s Neuralink company to implant a computer chip in your brain surgically? That’s not a farfetched question, given what happened this week.

According to an announcement this week, Elon Musk’s brain science company, Neuralink, has been given the green light by the U.S. Food and Drug Administration (FDA) to start its pioneering human clinical trials.

Neuralink was established by the well-known Tesla chief executive in 2016. The company’s primary focus is to create a cutting-edge device known as “the link,” which essentially acts as a bridge between the human brain and computers.

(After reading the rest of this post, share your reaction, thoughts, and opinion by emailing [email protected]. Would you volunteer to allow Elon Musk’s Neuralink company to implant a computer chip in your brain surgically?)

Musk explained that Neuralink aims to create a neural implant, which would be surgically placed into the brain. This revolutionary device could potentially help disabled patients regain mobility and communication abilities. There’s even hope that it may restore vision.

Neuralink tweeted: “This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people. Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!”

Elon Musk later celebrated the announcement on his Twitter account by congratulating the team at Neuralink.

Previously, Neuralink has made headlines with its experimental work on monkeys, pending FDA approval. Their groundbreaking research led to a monkey playing the video game pong purely with thought control.

In a previous address at Neuralink’s headquarters, Musk emphasized caution: “We want to be extremely careful and certain that it will work before putting a device into a human,” he said. “The progress at first, particularly as it applies to humans, will seem perhaps agonizingly slow, but we are doing all of the things to bring it to scale in parallel.”